- PI: Walter P. Weber
- study supported by EUBREAST
- trial design: phase 3, prospective randomised trial to examine tailored axillary surgery with or without axillary lymph node dissection in patiens with clinically node-positive breast cancer
- primary endpoint: disease-free survival
- Study protocol